Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Becton Dickinson and Company | BDX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
230.48 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 229.395 - 287.32 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 230.48 | USD |
Becton Dickinson and Company Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
66.59B | 288.90M | - | 19.37B | 1.42B | 4.93 | 46.76 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Becton Dickinson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 234.70 | 236.175 | 230.025 | 233.36 | 899,783 | -4.22 | -1.80% |
1 Month | 247.48 | 247.81 | 229.395 | 238.13 | 1,054,464 | -17.00 | -6.87% |
3 Months | 244.67 | 248.42 | 229.395 | 239.34 | 1,308,838 | -14.19 | -5.80% |
6 Months | 254.48 | 259.96 | 229.395 | 239.12 | 1,520,082 | -24.00 | -9.43% |
1 Year | 258.43 | 287.32 | 229.395 | 249.81 | 1,345,544 | -27.95 | -10.82% |
3 Years | 255.99 | 287.32 | 215.90 | 248.81 | 1,289,476 | -25.51 | -9.97% |
5 Years | 238.51 | 287.32 | 197.75 | 247.62 | 1,379,366 | -8.03 | -3.37% |
Becton Dickinson Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business. |